Correction (DOI:10.1016/j.annemergmed.2006.10.024);Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department with Acute Heart Failure Syndromes

Annals of Emergency Medicine

Volumn 49, Issue 5, 2007, Pages 627-669

  Silvers, Scott M ^a   Howell, John M ^a   Kosowsky, Joshua M ^a   Rokos, Ivan C ^a   Jagoda, Andy S ^a  

^a American Coll of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Acute H   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; BUMETANIDE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOXAZOSIN; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; ISOSORBIDE DINITRATE; MORPHINE; NESIRITIDE; PERINDOPRIL; PLACEBO; TORASEMIDE;

ACUTE HEART FAILURE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DYSPNEA; EMERGENCY MEDICINE; EMERGENCY PHYSICIAN; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; HEALTH CARE POLICY; HEART INFARCTION; HUMAN; LOW DRUG DOSE; MEDICAL LITERATURE; METHODOLOGY; MONOTHERAPY; OUTPATIENT; OXYGEN THERAPY; PATIENT CARE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TREATMENT RESPONSE;

EID: 34247139769     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2009.11.018     Document Type: Erratum

References (84)

1. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update (2005), American Heart Association, Dallas, TX
2. Nieminen M.S., Bohm M., Cowie M.R., et al. The Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 26 (2005) 384-416
3. American Heart Association. 2002 Heart and Stroke Statistical Update (2002), American Heart Association, Dallas, TX
4. Hunt S.A., American College of Cardiology, and American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-e82
5. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al., ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216
6. Gheorghiade M., Zannad F., Sopko G., et al., International Working Group on Acute Heart Failure Syndromes. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
7. Nohria A., Tsang S.W., Fang J.C., et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41 (2003) 1797-1804
8. Felker G.M., Adams Jr. K.F., Konstam M.A., et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145 (2003) S18-S25
9. Gheorghiade M., De Luca L., Fonarow G.C., et al. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 96 (2005) 11G-17G
10. Schriger D.L., Cantrill S.V., and Greene C.S. The origins, benefits, harms, and implications of emergency medicine clinical policies. Ann Emerg Med 22 (1993) 597-602
11. Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
12. Logeart D., Saudubray C., Beyne P., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 40 (2002) 1794-1800
13. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
14. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from breathing not properly (BNP) multinational study. Circulation 106 (2002) 416-422
15. Maisel A.S., Clopton P., Krishnaswamy P., et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study. Am Heart J 147 (2004) 1078-1084
16. Maisel A.S., McCord J., Nowak R.M., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. J Am Coll Cardiol 41 (2003) 2010-2017
17. McCullough P.A., Hollander J.E., Nowak R.M., et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10 (2003) 198-204
18. McCullough P.A., Duc P., Omland T., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the breathing not properly multinational study. Am J Kidney Dis 41 (2003) 571-579
19. McCord J., Mundy B.J., Hudson M.P., et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 164 (2004) 2247-2252
20. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
21. Krauser D.G., Lloyd-Jones D.M., Chae C.U., et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149 (2005) 744-750
22. Ray P., Arthaud M., Lefort Y., et al. Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea. Intensive Care Med 30 (2004) 2230-2236
23. Davis M., Espiner E., Richards G., et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 343 (1994) 440-444
24. Fleischer D., Espiner E.A., Yandle T.G., et al. Rapid assay of plasma brain natriuretic peptide in the assessment of acute dyspnea. N Z Med J 110 (1997) 71-74
25. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37 (2001) 379-385
26. Villacorta H., Duarte A., Duarte N.M., et al. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol 79 (2002) 569-572
27. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
28. Mueller C., Laule-Kilian K., Scholer A., et al. Use of B-type natriuretic peptide for the management of women with dyspnea. Am J Cardiol 94 (2004) 1510-1514
29. Mueller C., Laule-Kilian K., Scholer A., et al. B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison. Kidney Int 67 (2005) 278-284
30. Bayes-Genis A., Santalo-Bel M., Zapico-Muniz E., et al. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 6 (2004) 301-308
31. Alibay Y., Beauchet A., El Mahmoud R., et al. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Biomed Pharmacother 59 (2005) 20-24
32. Mueller T., Gegenhuber, Poelz W., et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91 (2005) 606-612
33. Ray P., Arthaud M., Birolleau S., et al. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older. J Am Geriatr Soc 53 (2005) 643-648
34. Lainchbury J.G., Campbell E., Frampton C.M., et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42 (2003) 728-735
35. Katz M.H., Nicholson B.W., Singer D.E., et al. The triage decision in pulmonary edema. J Gen Intern Med 3 (1988) 533-539
36. Rasanen J., Heikkila J., Downs J., et al. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Am J Cardiol 55 (1985) 296-300
37. Lin M., and Chiang H.-T. The efficacy of early continuous positive airway pressure therapy in patients with acute cardiogenic pulmonary edema. J Formos Med Assoc 90 (1991) 736-743
38. Bersten A.D., Holt A.W., Vedig A.E., et al. Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. N Engl J Med 325 (1991) 1825-1830
39. Baratz D.M., Westbrook P.R., Shah P.K., et al. Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure. Chest 102 (1992) 1397-1401
40. Lin M., Yang Y.-F., Chiang H.-T., et al. Reappraisal of continuous positive airway pressure therapy in acute cardiogenic pulmonary edema. Short-term results and long-term follow-up. Chest 107 (1995) 1379-1386
41. Lenique F., Habis M., Lofaso F., et al. Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med 155 (1997) 500-505
42. Kelly A.M., Georgakas C., Bau S., et al. Experience with the use of continuous positive airway pressure (CPAP) therapy in the emergency management of acute severe cardiogenic pulmonary oedema. Aust N Z J Med 27 (1997) 319-322
43. Takeda S., Nejima J., Takano T., et al. Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. Jpn Circ J 62 (1998) 553-558
44. L'Her E., Duquesne F., Girou E., et al. Noninvasive continuous positive airway pressure in elderly cardiogenic pulmonary edema patients. Intensive Care Med 30 (2004) 882-888
45. Pang D., Keenan S.P., Cook D.J., et al. The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. Chest 114 (1998) 1185-1192
46. Kelly C.A., Newby D.E., McDonagh T.A., et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema; effects on plasma brain natriuretic peptide concentrations. Eur Heart J 23 (2002) 1379-1386
47. Lapinsky S.E., Mount D.B., Mackey D., et al. Management of acute respiratory failure due to pulmonary edema with nasal positive pressure support. Chest 105 (1994) 229-231
48. Newberry III D.L., Noblett K.E., Kolhouse L., et al. Noninvasive bilevel positive pressure ventilation in severe acute pulmonary edema. Am J Emerg Med 13 (1995) 479-482
49. Sacchetti A.D., Harris R.H., Paston C., et al. Bi-level positive airway pressure support system use in acute congestive heart failure: preliminary case series. Acad Emerg Med 2 (1995) 714-718
50. Lo Coco A., Vitale G., Marchese S., et al. Treatment of acute respiratory failure secondary to pulmonary oedema with bi-level positive airway pressure by nasal mask. Monaldi Arch Chest Dis 52 (1997) 444-446
51. Rusterholtz T., Kempf J., Berton C., et al. Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema (ACPE). Intensive Care Med 25 (1999) 21-28
52. Mehta S., Jay G.D., Woolard R.H., et al. Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. Crit Care Med 25 (1997) 620-628
53. Masip J., Betbese A.J., Paez J., et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial. Lancet 356 (2000) 2126-2132
54. Sharon A., Shpirer I., Kaluski E., et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 36 (2000) 832-837
55. Levitt M.A. A prospective, randomized trial of BiPAP in severe acute congestive heart failure. J Emerg Med 21 (2001) 363-369
56. Chadda K., Annane D., Hart N., et al. Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. Crit Care Med 30 (2002) 2457-2461
57. Bellone A., Monari A., Cortellaro F., et al. Myocardial infarction rate in acute pulmonary edema: noninvasive pressure support ventilation versus continuous positive airway pressure. Crit Care Med 32 (2004) 1860-1865
58. Cotter G., Metzkor E., Kaluski E., et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 351 (1998) 389-393
59. Vasodilation in the Management of Acute CHF (VMAC) Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 (2002) 1531-1540
60. Abraham W.T., Adams K.F., Fonarow G.C., et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46 (2005) 57-64
61. Abraham W.T., Lowes B.D., Ferguson D.A., et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 4 (1998) 37-44
62. Mills R.M., LeJemtel T.H., Horton D.P., et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure. J Am Coll Cardiol 34 (1999) 155-162
63. Colucci W.S., Elkayam U., Horton D.P., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 343 (2000) 246-253
64. Burger A.J., Horton D.P., LeJemtel T., et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 144 (2002) 1102-1108
65. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
66. Sackner-Bernstein J.D., Kowalski M., Fox M., et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293 (2005) 1900-1905
67. Peacock W., Emerman C., and The PROACTION Study Group. Safety and efficacy of nesiritide in the treatment of decompensated heart failure in observation patients. J Am Coll Cardiol 41 (2003) 336A
68. Abraham W.T. Nesiritide and mortality risk: individual and pooled analyses of randomized controlled clinical trials. Previews in Cardiovascular Medicine (2005) MedReviews, LLC. Sponsored by Scios Inc.
69. Verma S.P., Silke B., Reynolds G.W., et al. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, α-adrenoceptor blockade, and angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 20 (1992) 274-281
70. Agusti A., Bonet S., Arnau J.M., et al. Adverse effects of ACEP inhibitors in patients with chronic heart failure and /or ventricular dysfunction: meta-analysis of randomised clinical trials. Drug Saf 26 (2003) 895-908
71. Anthopoulos L., Apostolou T., Bonoris P., et al. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure. Curr Med Res Opin 17 (2001) 290-297
72. McElnay J.C., Al-Furaih T.A., Hughes C.M., et al. A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure. Eur J Clin Pharmacol 49 (1996) 471-476
73. Podbregar M., Voga G., Horvat M., et al. Bolus versus continuous low dose of enalaprilat in congestive heart failure with acute refractory decompensation. Cardiology 91 (1999) 41-49
74. Vitovec J., Spinar J., and Czech and Slovak Investigator Group. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Eur J Heart Fail 2 (2000) 299-304
75. Francis G.S., Siegel R.M., Goldsmith S.R., et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 103 (1985) 1-6
76. Nelson G.I.C., Silke B., Ahuja R.C., et al. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart failure following myocardial infarction. Lancet 1 (1983) 730-733
77. Nelson G.I.C., Silke B., Forsyth D.R., et al. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. Am J Cardiol 52 (1983) 1036-1040
78. Nelson G.I.C., Silke B., Ahuja R.C., et al. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction. Am Heart J 107 (1984) 1202-1209
79. Kraus P.A., Lipman J., and Becker P.J. Acute preload effects of furosemide. Chest 98 (1990) 124-128
80. Hoffman J.R., and Reynolds S. Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. Chest 4 (1987) 586-593
81. Butler J., Forman D.E., Abraham W.T., et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147 (2004) 331-338
82. Fonarow G.C., Adams Jr. K.F., Abraham W.T., et al., ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis. JAMA 293 (2005) 572-580
83. Krumholz H.M., Chen Y.T., Vaccarino V., et al. Correlates and impact on outcomes of worsening renal function in patients >65 years of age with heart failure. Am J Cardiol 85 (2000) 1110-1113
84. Smith G.L., Vaccarino V., Kosiborod M., et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?. J Card Fail 9 (2003) 13-25